Isoray, Inc.
ASE:ISR 3:30:31 PM EDT
| Market Cap (Intraday) | 88.53M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $0.63 |
| 50-Day MA | $0.64 |
| 200-Day MA | $0.97 |
Isoray, Inc. Stock, ASE:ISR
350 Hills Street, Suite 106, Richland, Washington 99354-5511
United States of America
Phone: +1.509.375.1202
Number of Employees: 67
Description
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA.